Looking back on biotechnology stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Incyte ...

The average one-year price target for Nautilus Biotechnology (NasdaqCM:NAUT) has been revised to $4.08 / share. This is an ...

Add Yahoo as a preferred source to see more of our stories on Google. Lululemon launched its first product using plant-based nylon in April 2023 Biotechnology is the exploitation of biological ...

Shares Biotechnology ETF (IBB) gives investors biotech exposure through large, established drug developers rather than ...

Insilico Medicine ("Insilico", 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven biotechnology ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine, as global R&D investment approaches $360 billion ...

Curative Biotechnology, Inc. (OTC: CUBTD) ("Curative” or the "Company”), a development-stage biomedical company focused on novel treatments for degenerative eye diseases, today announced a reverse ...

PDS Biotechnology Corporation (PDSB) on Monday reported a loss of $7.6 million in its fourth quarter. The East Princeton, New Jersey-based company said it had a loss of 14 cents per share. For the ...

Debut Biotech, a company innovating new molecules, is partnering with Image Skincare to launch a new beauty product, CNBC has learned. The San Diego-based company uses biotechnology and artificial ...

Biotech stocks surged in 2025, driven by FDA approvals, M&A activity, and rising longevity investment. Explore key trends, ...

Vir Biotechnology Reports Positive Updated Phase 1 Results for PSMA-targeting, PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 in Patients with Metastatic Prostate Cancer – Updated Phase 1 ...

In the rapidly evolving field of industrial biotechnology, bacteria have emerged as crucial agents driving innovation and sustainable development.